undamentalytics Newsletter
Sign in

Sintx Technologies, Inc. income statement

In fiscal 2025, Sintx Technologies, Inc. reported revenue of $1.0m, down 64.7% on the year before, operating income of −$10.7m (a -1053.1% margin) and net income of −$10.4m, or −$6.16 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue2223191511011123311
Cost of revenue78646010001111
Gross profit151513115000012201
Research and development37664335669553
Selling and marketing161912100001111101
General and administrative614664433444468
Operating income−10−24−12−12−7−13−7−9−11−11−13−14−11−12
Interest expense24————————————
Income before tax−8−33−24−15−6−10−5−7−9−12−8−11−10−11
Net income−8−33−24−15−9−9−5−7−9−12−8−11−10−11
Diluted EPS−$3.88−$5989500.00−$9907500.00−$2044500.00−$469500.00−$1534600.00−$113800.00−$21600.00−$7982.00−$12162.00−$624.47−$15.19−$6.16—
Diluted shares (average)————20m19m——————3m—
EBITDA−9−22−10−10−7−13−6−8−10−11−12−13−10−11

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: NXGL vs SINTOSUR vs SINTMDXG vs SINT

More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies

Figures from Sintx Technologies, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sintx Technologies, Inc.